United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 8, 2026 · Filed Sep 9, 2026

On Sep 8, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$499.03 for US$4.74M under a trading plan, leaving 324,443 shares. Filed Sep 9, 2026 (Form 4).

Sold
9,500 shares
Price
US$499.03 average (US$481.91 to US$504.15)
Value
US$4.74M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 8, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 8, 2026Common StockSale40US$481.91333,903Indirect
Sep 8, 2026Common StockSale200US$483.90333,703Indirect
Sep 8, 2026Common StockSale220US$491.04333,483Indirect
Sep 8, 2026Common StockSale140US$492.72333,343Indirect
Sep 8, 2026Common StockSale144US$493.98333,199Indirect
Sep 8, 2026Common StockSale600US$494.87332,599Indirect
Sep 8, 2026Common StockSale256US$495.75332,343Indirect
Sep 8, 2026Common StockSale300US$497.05332,043Indirect
Sep 8, 2026Common StockSale1,902US$498.18330,141Indirect
Sep 8, 2026Common StockSale1,018US$498.77329,123Indirect
Sep 8, 2026Common StockSale1,173US$500.20327,950Indirect
Sep 8, 2026Common StockSale1,221US$501.17326,729Indirect
Sep 8, 2026Common StockSale1,167US$502.26325,562Indirect
Sep 8, 2026Common StockSale701US$503.33324,861Indirect
Sep 8, 2026Common StockSale418US$504.15324,443Indirect

Source

View original at SEC

Related